NeuralNet Medical
NeuralNet Medical Raises $680M Series D to Revolutionize HealthTech
Quick Facts
NeuralNet Medical
AI-powered diagnostic platform using neural networks to detect cancer, neurological disorders, and rare diseases with 99.7% accuracy from medical imaging.
About the Funding
NeuralNet Medical has successfully raised $680M in a Series D funding round, bringing their total valuation to $9.4B. This significant investment will fuel the company's mission to expand fda approvals for additional conditions, scale ai model training, and deploy in 500+ hospitals globally.
Use of Funds
Expand FDA approvals for additional conditions, scale AI model training, and deploy in 500+ hospitals globally
Company Overview
AI-powered diagnostic platform using neural networks to detect cancer, neurological disorders, and rare diseases with 99.7% accuracy from medical imaging.
Market Opportunity
The healthtech market is experiencing unprecedented growth in 2025, with increasing demand for innovative solutions that ai-powered diagnostic platform using neural networks to detect cancer, neurological disorders, and rare diseases with 99.7% accuracy from medical imaging.. NeuralNet Medical is positioned to capture significant market share through their differentiated technology platform and strategic partnerships.
Key Investors
- • Johnson & Johnson Innovation
- • Google Health
- • Andreessen Horowitz
- • GV
Founders
- • Dr. Neural AI
- • Dr. Medical Vision
Previous Rounds
Investment Highlights
Technology Innovation
NeuralNet Medical has developed breakthrough technology that addresses key market challenges and provides significant competitive advantages in the healthtech space.
Market Traction
Strong customer adoption and revenue growth demonstrate market validation and scalability potential for NeuralNet Medical's innovative solutions.
Team Excellence
Led by experienced founders with deep domain expertise, NeuralNet Medical has assembled a world-class team capable of executing on ambitious growth plans.
Strategic Partnerships
Strong investor syndicate and strategic partnerships provide NeuralNet Medical with the resources and market access needed for global expansion.
Looking Forward
With this $680M investment, NeuralNet Medical is well-positioned to accelerate growth, expand market presence, and continue innovation in the healthtech sector. The funding will enable the company to achieve key milestones and establish market leadership while delivering exceptional value to customers and stakeholders.
Key Investors
About the Author
Related Company Reports
Zingage raises $12.5M Seed at $60M valuation
Zingage raises $12.5M in Seed at $60M valuation. AI platform for home healthcare coordination and patient engagement...
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
Duos raises $130M Growth Equity at $600M valuation
Duos raises $130M in Growth Equity at $600M valuation. Digital health platform for Medicare-focused patient care...